| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/28/1997 | CA2187911A1 Prolongation of organ transplantation using rapamycin loaded donor splenocytes |
| 04/24/1997 | WO1997014964A2 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014782A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014306A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | WO1997007823A3 Compositions and their uses |
| 04/24/1997 | WO1997005267A3 Mucosal delivery of polynucleotides |
| 04/24/1997 | DE19540475A1 Chirale Methylphenyloxazolidinone Chiral methylphenyloxazolidinones |
| 04/24/1997 | CA2235245A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | CA2234088A1 Patient-specific immunoadsorbents for extracorporal apheresis and methods for their preparation |
| 04/23/1997 | EP0769147A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769022A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 04/23/1997 | EP0769020A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 04/23/1997 | EP0769006A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768893A1 Polynucleotide vaccine for papillomavirus |
| 04/23/1997 | EP0768890A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0768881A2 Anti-hiv triple combination |
| 04/23/1997 | EP0670825B1 Nitric esters having a pharmacological activity and process for their preparation |
| 04/23/1997 | EP0656844B1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 04/23/1997 | EP0655927B1 Interleukin-4 stimulated t lymphocyte cell death |
| 04/23/1997 | CN1148389A Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
| 04/22/1997 | US5623056 Immunomodulators |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622984 Amidinophenol derivatives |
| 04/22/1997 | US5622970 Controlling graft rejection |
| 04/22/1997 | US5622963 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622848 Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| 04/22/1997 | US5622706 Synthetic polypeptide comprising amino acid sequence of mature stx gene; accellular vaccines |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | US5622700 Administering initial dosage of antibody, subsequent intermittent dosing |
| 04/22/1997 | CA2029776C Selenophen derivatives, a preparation process of the same and therapeutical compositions containing them |
| 04/17/1997 | WO1997014038A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013751A1 Indole carbamates as leukotriene antagonists |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013502A2 Prolonged release of gm-csf |
| 04/17/1997 | DE19538641A1 Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung Patient-specific immuno for extracorporeal apheresis and methods for their preparation |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2491511A1 Prolonged release of gm-csf |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2233313A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768089A1 Health composition |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767677A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 04/16/1997 | EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 04/16/1997 | EP0767672A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis |
| 04/16/1997 | EP0767664A2 Combination therapy for hiv infection |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | EP0669923B1 Rapamycin carbonate esters as immunosuppressant agents |
| 04/16/1997 | EP0630259B1 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1034572C Cyclic anthranilicacid acetic acid derivatives and process for prepn. |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621083 Immunotoxins comprising ribosome-inactivating proteins |
| 04/15/1997 | US5621076 Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 04/15/1997 | US5621012 Active compound combinations having a content of glyceryl alkyl ethers and cosmetic and dermatological formulations comprising such active compound combinations |
| 04/15/1997 | US5621001 Methods for administration of taxol |
| 04/15/1997 | US5621000 Nitric esters having a pharmacological activity and process for their preparation |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620956 Inhibiting differentiation of cytotoxic t-lymphocyte precursor to mature cell specific for foreign antigen |
| 04/15/1997 | US5620889 Human anti-Fas IgG1 monoclonal antibodies |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/10/1997 | WO1997012963A2 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012894A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012867A1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997012626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 04/10/1997 | WO1997012617A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | DE19537012A1 Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung A cyclosporin (s) enhaltende pharmaceutical preparation for oral administration and processes for their preparation |
| 04/10/1997 | CA2234229A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233300A1 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2231505A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |